These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24913933)
1. Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy. Tawdy MH; Abd El Nasser MM; Abd El Shafy SS; Nada MA; El Sirafy MN; Magd AH J Clin Neurosci; 2014 Sep; 21(9):1606-11. PubMed ID: 24913933 [TBL] [Abstract][Full Text] [Related]
2. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757 [TBL] [Abstract][Full Text] [Related]
14. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346 [TBL] [Abstract][Full Text] [Related]
15. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway. Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402 [TBL] [Abstract][Full Text] [Related]
16. TRAIL gene expression analysis in multiple sclerosis patients. Taheri M; Nemati S; Movafagh A; Saberi M; Mirfakhraie R; Eftekharian MM; Arsang-Jang S; Rezagholizadeh A; Sayad A Hum Antibodies; 2016 May; 24(1-2):33-8. PubMed ID: 27472871 [TBL] [Abstract][Full Text] [Related]
17. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia. Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753 [TBL] [Abstract][Full Text] [Related]
18. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. Ishikawa E; Nakazawa M; Yoshinari M; Minami M J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918 [TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy. Chang WW; Liang W; Yao XM; Zhang L; Zhu LJ; Yan C; Jin YL; Yao YS J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318785744. PubMed ID: 29999450 [TBL] [Abstract][Full Text] [Related]
20. Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis. Moreno M; Sáenz-Cuesta M; Castilló J; Cantó E; Negrotto L; Vidal-Jordana A; Montalban X; Comabella M J Neuroimmunol; 2013 Oct; 263(1-2):152-4. PubMed ID: 23932896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]